Drug metabolism in human HepG2 cells assessed as SSAT1-mediated (N12-acetyl)-1,12-diamino-3,6,9-triazadodecane formation at 100 uM for 24 hrs pretreated with 50 uM DENSpm for 24 hrs
Drug metabolism in human HepG2 cells assessed as SSAT1-mediated (N1-acetyl)-1,12-diamino-3,6,9-triazadodecane formation at 100 uM for 24 hrs in presence of SSAT2 shRNA
Drug metabolism in mouse primary hepatocytes assessed as SSAT1-mediated (N1-acetyl)-1,12-diamino-3,6,9-triazadodecane formation at 100 uM for 4 hrs in presence of SSAT2 siRNA
Drug metabolism in human HepG2 cells assessed as SSAT1-mediated (N1-acetyl)-1,12-diamino-3,6,9-triazadodecane formation at 100 uM for 24 hrs pretreated with 50 uM DENSpm for 24 hrs